Rtw Investments, LP Protagonist Therapeutics, Inc Transaction History

Rtw Investments, LP

$6.27 Billion
Q3 2024

A detailed history of Rtw Investments, LP transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Rtw Investments, LP holds 5,426,112 shares of PTGX stock, worth $221 Million. This represents 3.89% of its overall portfolio holdings.

Number of Shares

5,426,112

Previous 5,286,404 2.64%

Holding current value

$221 Million

Previous $183 Million 33.12%

% of portfolio

3.89%

Previous 3.06%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$33.72 - $47.33 $4.71 Million - $6.61 Million	139,708 Added 2.64%	5,426,112 $244 Million
Q2 2024 Aug 14, 2024	SELL	$24.66 - $34.8 $717,852 - $1.01 Million	-29,110 Reduced 0.55%	5,286,404 $183 Million
Q4 2023 Feb 14, 2024	SELL	$14.05 - $23.44 $1.41 Million - $2.34 Million	-100,000 Reduced 1.85%	5,315,514 $122 Million
Q2 2023 Aug 14, 2023	BUY	$18.02 - $29.36 $14.7 Million - $23.9 Million	814,715 Added 17.71%	5,415,514 $150 Million
Q1 2023 May 15, 2023	BUY	$10.78 - $25.38 $10.9 Million - $25.6 Million	1,008,813 Added 28.09%	4,600,799 $106 Million
Q4 2022 Feb 14, 2023	SELL	$7.36 - $11.17 $4.3 Million - $6.53 Million	-584,851 Reduced 14.0%	3,591,986 $39.2 Million
Q3 2022 Nov 14, 2022	SELL	$7.86 - $11.71 $4.85 Million - $7.23 Million	-617,662 Reduced 12.88%	4,176,837 $35.2 Million
Q1 2022 May 16, 2022	BUY	$23.34 - $36.08 $51.2 Million - $79.2 Million	2,194,677 Added 84.42%	4,794,499 $114 Million
Q4 2021 Feb 14, 2022	BUY	$17.63 - $37.1 $14.9 Million - $31.4 Million	846,127 Added 48.25%	2,599,822 $88.9 Million
Q3 2021 Nov 15, 2021	SELL	$12.95 - $49.69 $22.7 Million - $87.1 Million	-1,753,695 Reduced 50.0%	1,753,695 $31.1 Million
Q1 2021 May 14, 2021	SELL	$19.02 - $31.15 $2.71 Million - $4.44 Million	-142,679 Reduced 3.91%	3,507,390 $90.8 Million
Q4 2020 Feb 16, 2021	BUY	$18.49 - $25.13 $4.46 Million - $6.06 Million	241,108 Added 7.07%	3,650,069 $73.6 Million
Q3 2020 Nov 16, 2020	BUY	$15.19 - $22.4 $391,188 - $576,867	25,753 Added 0.76%	3,408,961 $66.6 Million
Q2 2020 Aug 14, 2020	BUY	$6.19 - $18.84 $4.47 Million - $13.6 Million	722,816 Added 27.17%	3,383,208 $59.7 Million
Q1 2020 May 15, 2020	BUY	$5.4 - $9.22 $1.08 Million - $1.85 Million	200,404 Added 8.15%	2,660,392 $18.8 Million
Q4 2019 Feb 14, 2020	BUY	$4.69 - $13.45 $7.96 Million - $22.8 Million	1,697,705 Added 222.71%	2,459,988 $17.3 Million
Q3 2019 Nov 14, 2019	BUY	$9.41 - $16.56 $7.17 Million - $12.6 Million	762,283 New	762,283 $9.16 Million

Others Institutions Holding PTGX

# of Institutions

247

Shares Held

56.4M

Call Options Held

76.3K

Put Options Held

114K

View Full List

About Protagonist Therapeutics, Inc

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

More about PTGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rtw Investments, LP with notifications on news.

Account

Rtw Investments, LP Protagonist Therapeutics, Inc Transaction History